Sumitomo Heavy Industries Announces Start of BNCT Treatment in China's Hainan Island Medical Special Zone
NQ Score
0/100
N1 Content Completeness
0
AI Summary (NQ-processed)
Sumitomo Heavy Industries, Ltd. has announced the commencement of its first practical clinical treatment using its BNCT system, 'NeuCure®', in the Hainan Bo'ao Lecheng International Medical Tourism Pilot Zone in China. This marks a significant step towards market expansion in China and leverages the special zone's regulatory advantages.